US Stock MarketDetailed Quotes

Vanda Pharmaceuticals (VNDA)

Watchlist
  • 6.390
  • -0.040-0.62%
Close May 14 16:00 ET
  • 6.500
  • +0.110+1.72%
Post 17:29 ET
384.27MMarket Cap-1.57P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vanda Pharmaceuticals (VNDA) Revenue Breakdown Overview

By Business/Source

Currency:USD
2026/Q1
Stock NameRevenueRatio
Fanapt ® net product sales29.56M57.16%
HETLIOZ ® net product sales15.95M30.83%
PONVORY ® net product sales6.21M12.01%

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United States216.11M100.00%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.75%
Sample Name
Sample Code
 +15.52%
Sample Name
Sample Code
 +14.53%
4
United States Oil Fund LP
USO
+13.64%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.14%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.99%
Sample Name
Sample Code
 +9.49%
Sample Name
Sample Code
 +8.77%
4
Hesai
HSAI
+8.01%
5
NIO Inc
NIO
+6.47%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -